These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3172841)

  • 41. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy.
    Opalka B; Wandl U; Beer U; Roggenbuck U; Kloke O; Niederle N
    Leukemia; 1991 Jun; 5(6):452-6. PubMed ID: 2056769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
    Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
    Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia.
    Shtalrid M; Talpaz M; Kurzrock R; Kantarjian H; Trujillo J; Gutterman J; Yoffe G; Blick M
    Blood; 1988 Aug; 72(2):485-90. PubMed ID: 3165294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.
    Kolomietz E; Marrano P; Yee K; Thai B; Braude I; Kolomietz A; Chun K; Minkin S; Kamel-Reid S; Minden M; Squire JA
    Leukemia; 2003 Jul; 17(7):1313-23. PubMed ID: 12835719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes.
    Dubé I; Dixon J; Beckett T; Grossman A; Weinstein M; Benn P; McKeithan T; Norman C; Pinkerton P
    Genes Chromosomes Cancer; 1989 Sep; 1(1):106-11. PubMed ID: 2487142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
    Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
    Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant methylation of the major breakpoint cluster region in chronic myeloid leukemia.
    Litz CE; Vos JA; Copenhaver CM
    Blood; 1996 Sep; 88(6):2241-9. PubMed ID: 8822945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukemia.
    Jaubert J; Martiat P; Dowding C; Ifrah N; Goldman JM
    Br J Haematol; 1990 Jan; 74(1):30-5. PubMed ID: 2310695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia.
    Benn P; Soper L; Eisenberg A; Silver RT; Coleman M; Cacciapaglia B; Bennett L; Baird M; Silverstein M; Berger C
    Cancer Genet Cytogenet; 1987 Nov; 29(1):1-7. PubMed ID: 2822224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia.
    Heisterkamp N; Knoppel E; Groffen J
    Nucleic Acids Res; 1988 Nov; 16(21):10069-81. PubMed ID: 3194194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.
    Krumbholz M; Karl M; Tauer JT; Thiede C; Rascher W; Suttorp M; Metzler M
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1045-53. PubMed ID: 22887688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further evidence for the molecular heterogeneity of chronic myeloid leukemia.
    Hernandez A; Corral L; Muñiz A; Alaez C; Espinosa E; Martinez G; Hernandez P
    Ann Hematol; 1991 Jun; 62(6):217-20. PubMed ID: 1854884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.
    Giere IA; Larripa IB
    Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis.
    Przepiorka D
    Cancer Genet Cytogenet; 1988 Nov; 36(1):117-22. PubMed ID: 3203293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemia.
    Melani C; Canepa L; Sessarego M; Miglino M; Ferraris AM; Gaetani GF
    Eur J Haematol; 1989 Jan; 42(1):32-7. PubMed ID: 2914593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
    Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
    Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location.
    Elliott SL; Taylor KM; Taylor DL; Rodwell RL; Williams BF; Shuttlewood MM; Wright SJ; Eliadis PE; Bunce IH; Frost TJ
    Leukemia; 1995 Jun; 9(6):946-50. PubMed ID: 7596182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.